Trial intelligence / Profile preview

Safety and tolerability of EPs 7630 syrup vs solution in young children with acute bronchitis

2011-002652-14Phase 4Completed

Sponsor
Schwabe Group
Start
Aug 2011
Countries
1
01

Overview

Phase 4 trial of pelargonium sidoides extract in acute bronchitis (2 arms), sponsored by Schwabe Group. Primary endpoint: Safety and tolerability. Started Aug 2011; status: completed.

02

Drugs

pelargonium sidoides extract
03

Conditions

acute bronchitis

Beyond the preview

Go deeper on 2011-002652-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002652-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call